LAS VEGAS, April 8 Natalie Curry has the most extraordinary story to tell about how umbilical cord blood saved her life. She will now tell the story, and much more, as official spokesperson for Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ), focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally.
Natalie was diagnosed at age one with Fanconi's Anemia, a rare, certain to be fatal blood disorder. The only hope was a bone marrow transplant and Natalie's parents conceived two children in hopes that the bone marrow of a sibling would be a suitable match for Natalie.
Discussions between Natalie's mother and her doctors led to a decision to attempt a medical first: To save Natalie's sister's umbilical cord blood and to use it, rather than the bone marrow, for the transplant. In 1989, doctors from all over gathered in 1989 in St. Louis Hospital in Paris to watch the procedure. Natalie's transplant was a huge success, she is now 25 years old, and her blog at www.nataliecurry.com will serve to provide information and anecdotes about the importance of saving umbilical cord blood stem cells at birth.
"I don't believe there is a more dedicated, knowledgeable layman in this entire field than Natalie. Her web site erupts with enthusiasm for the importance of stem cell storage and we invite our investors to visit her site," said Matthew Schissler, Cord Blood America co-founder and CEO. "Natalie will be writing articles for CBAI, blogging about stem cells and their benefits, she will hold Webinars for expecting families and will be a guest contributor to our Corporate-sponsored sites. We are delighted to welcome Natalie to the Cord Blood America family."
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT: Paul Knopick E & E Communications 949/707-5365 email@example.com
SOURCE Cord Blood America, Inc.